Skip to main content
SpringerLink
Log in

Lack of Hepatocyte Growth Factor Receptor (c-met) Gene Expression in Fulminant Hepatic Failure Livers Before Transplantation

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

To gain insight into liver regenerationmechanisms in fulminant hepatic failure, we comparedgene expression of hepatocyte growth factor, itsreceptor c-met, c-myc, and albumin in human normal (4cases) and fulminant (14 cases) livers by reversetranscription-polymerase chain reaction. In normallivers, hepatocyte growth factor gene was not expressed,whereas c-met, c-myc and albumin genes were always expressed. In fulminant hepatic failure,hepatocyte growth factor gene was expressed in 1 of 14cases, c-met in none of 14 cases, c-myc in 10 of 14cases, and albumin in 3 of 14 cases. Byimmunofluorescence, c-met protein was revealed in normal but not infulminant hepatic failure liver tissue. Liver tissue isunlikely to account for high hepatocyte growth factorplasma levels typical for fulminant hepatic failure. Lack of its receptor (c-met)expression may explain a poor response of fulminanthepatic failure livers to exogenous hepatocyte growthfactor that normally promotes liver growth andregeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Trey C, Davidson C: The management of fulminant hepatic failure. Prog Liver Dis 3:282–298, 1970

    Google Scholar 

  2. Hanau C, Santiago J, Rubin R: Histopathological heterogeneity in fulminant hepatic failure. Hepatology 21:345–351, 1995

    Google Scholar 

  3. Jones AE, Schafer DF: Fulminant hepatic failure. In Hepatology: A Textbook of Liver Disease. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders, 1990, pp 460–475

    Google Scholar 

  4. Kan M, Zhang GH, Zarnegar R, Michalopoulos GK, Myiken Y, McKeehan W, Stevens JL: Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem Biophys Res Commun 174:331–337, 1991

    Google Scholar 

  5. Matsumoto K, Tajima H, Nakamura T: Hepatocyte growth factor is a potent stimulator of human melanocytes DNA synthesis and growth. Biochem Biophys Res Commun 176:45–51, 1991

    Google Scholar 

  6. Rosen E, Meromsky L, Setter E, Vinter DW, Goldberg ID: Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10:49–64, 1990

    Google Scholar 

  7. Nakamura T: In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-met Receptor. ID Goldberg, EM Rosen (eds). Basel, Birkhäuser Verlag, 1993, pp 225–249

    Google Scholar 

  8. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM: Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 6:501–504, 1991

    Google Scholar 

  9. Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muto Y, Daikuhara Y, Hashimoto S: Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 6:875–881, 1989

    Google Scholar 

  10. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzymelinked immunosorbent assay. Hepatology 13:1–5, 1991

    Google Scholar 

  11. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T: Serum hepatocyte growth factor levels in liver diseases: Clinical implications. Hepatology 21:106–112, 1995

    Google Scholar 

  12. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, Cline MJ: Alterations of c-myc, myb, and rasHa protooncogenes in cancer are frequent and show clinical correlation. Science 231:261–263, 1986

    Google Scholar 

  13. Fausto N, Shank PR: Analysis of proto-oncogene expression during liver regeneration and hepatic cancinogenesis. In Neoplasms of the Liver. K Okuda, S Ishak (eds). New York, Springer-Verlag, 1987, pp 57–78

    Google Scholar 

  14. Ljubimova JY, Petrovic LM, Wilson SE, Geller SA, Demetriou AA: Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem 45:79–87, 1997

    Google Scholar 

  15. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467, 1977

    Google Scholar 

  16. Lindros PM, Zarnegar R, Michalopoulos GK: Hepatocyte growth factor rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 13:743–749, 1991

    Google Scholar 

  17. Matsumoto K, Nakamura T: Roles of HGF as a pleiotropic factor in organ regeneration. In Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-met Receptor. ID Goldberg, EM Rosen (eds). Basel, Birkhäuser Verlag, 1993, pp 1–29

    Google Scholar 

  18. Grigioni WF, Fiorentino M, D'Errico A, Ponzetto A, Crepaldi T, Prat M, Comoglio PM: Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. Hepatology 21:1543–1546, 1995

    Google Scholar 

  19. Miki C, Iriyama K, Straine A, Harrison JD, Hirono S, Bridget GK, Sherwell JM, Suzuki H, McMaster P: Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. Surgery 119:505–510, 1996

    Google Scholar 

  20. Villamil FG, Hu K-Q, Yu C-H, Lee C-H, Rojter SE, Podesta LG, Makowka L, Geller SA, Vierling JM: Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure. Hepatology 22:1379–1386, 1995

    Google Scholar 

  21. Chenard-Neu M-P, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, Domergue J, Durand F, Erhard J, De Hemptinne B, Gubernatis G, Hadengue A, Kemnitz J, McCarthy M, Maschek H, Mentha G, Oldhafer K, Portmann B, Praet M, Ringers J, Rogiers X, Rubbia L, Schalm S, Kate FT, Terpstra O, Van Hoek B, Williams R, Zafrani E-S, Cinqualbre J, Wolf P, Jaeck D, Bellocq J-P: Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure—a multicenter European study. Hepatology 23:1119–1127, 1996

    Google Scholar 

  22. Schwab M, Ramsay G, Alitalo K, Varmus HE, Bishop JM, Martinsson T, Levan G, Levan A: Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells. Nature 315:345–347, 1985

    Google Scholar 

  23. Petrovic LM, Ljubimova JY, Kamlot A, Geller SA, Demetriou AA: Is the postperfusion liver injury HGF-related? Lab Invest 76:154A, 1997

    Google Scholar 

  24. Finke J, Fritzen R, Ternes P, Lange W, Dölken G: An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques 14:448–453, 1993

    Google Scholar 

  25. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R: Modulation of c-met proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-met transcript. Oncogene 9:2045–2052, 1994

    Google Scholar 

  26. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G: Sequence of MET protooncogene cDNA has features characteristic of tyrosine family of growth factor receptors. Proc Natl Acad Sci USA 84:6379–6383, 1987

    Google Scholar 

  27. Rodrigues GA, Naujokas MA, Park M: Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol 11:2962–2970, 1991

    Google Scholar 

  28. Lee C-C, Yamada KM: Identification of a novel type of alternative splicing of a tyrosine kinase receptor. J Biol Chem 269:19457–19461, 1994

    Google Scholar 

  29. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF: Met expression and sarcoma tumorigenicity. Cancer Res 53:5355–5360, 1993

    Google Scholar 

  30. Eguchi S, Kamlot A, Ljubimova JY, Hewitt W, Lebow LT, Demetriou AA, Rozga J: Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology 24:1452–1460, 1996

    Google Scholar 

Download references

Authors
  1. Julia Y. Ljubimova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lidija M. Petrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolaos Arkadopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pierre Blanc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen A. Geller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Achilles A. Demetriou
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljubimova, J.Y., Petrovic, L.M., Arkadopoulos, N. et al. Lack of Hepatocyte Growth Factor Receptor (c-met) Gene Expression in Fulminant Hepatic Failure Livers Before Transplantation. Dig Dis Sci 42, 1675–1680 (1997). https://doi.org/10.1023/A:1018805330280

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018805330280

Search

Navigation